• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国浙江 COVID-19 患者不同亚型的临床特征及疾病严重程度的危险因素。

Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Infect Dis Poverty. 2020 Jul 8;9(1):85. doi: 10.1186/s40249-020-00710-6.

DOI:10.1186/s40249-020-00710-6
PMID:32641121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7341711/
Abstract

BACKGROUND

The outbreak of coronavirus disease 2019 (COVID-19) is now becoming an enormous threat to public health. The clinical spectrum of COVID-19 is extensive, of which critical cases are with rapid disease progression and high mortality. The aim of our study is to summarize the characteristics of different subtypes and explore risk factors of illness severity for early identification and prompt treatment.

METHODS

In this retrospective study, we collected data of patients confirmed COVID-19 in Zhejiang Province from 17 January to 12 February 2020. According to the definition of clinical classification, we divided confirmed cases into four types, and summarize epidemiological and clinical characteristics, laboratory and radiograph findings, treatments, and outcomes, respectively. Moreover, we used univariate and multivariate ordinal logistic regression models to explore risk factors for the severity of illness in patients with COVID-19.

RESULTS

A total of 788 patients were enrolled in our study, of whom 52 cases (6.6%) were mild type, 658 cases (83.5%) were common type, 61 cases (7.2%) were severe type, and 17 cases (2.2%) were critical type. Multivariate ordinal logistic regression demonstrated increasing odds of the severity of illness in patients with COVID-19 associated with male (odds ratio [OR] = 1.7, 95% confidence interval [CI]: 1.2-2.6 P = 0.008), fever (OR = 3.6, 95% CI: 2.1-6.3, P <  0.001), cough (OR = 1.7, 95% CI: 1.0-2.9, P = 0.041), hemoptysis (OR = 3.4, 95% CI: 1.1-10.3, P = 0.032), gastrointestinal symptoms (OR = 1.9, 95% CI: 1.0-3.5, P = 0.047), hypertension (OR = 2.6, 95% CI: 1.2-5.6, P = 0.013). With the increase of age-grading, risk for the severity of illness was gradually higher (≤ 18 years [OR = 1.0], 19-40 years [OR = 12.7, 95% CI: 4.5-36.0, P < 0.001], 41-65 years [OR = 14.8, 95% CI: 5.2-42.1, P <  0.001], ≥ 66 years [OR = 56.5, 95% CI: 17.1-186.5, P < 0.001]).

CONCLUSIONS

Clinicians should pay close attention to these features in patients with COVID-19 including older age, male, fever, cough, hemoptysis, gastrointestinal symptoms and hypertension to identify the severity of illness as early as possible.

摘要

背景

2019 年冠状病毒病(COVID-19)的爆发现在对公众健康构成了巨大威胁。COVID-19 的临床谱广泛,其中重症病例疾病进展迅速,死亡率高。我们研究的目的是总结不同亚型的特征,并探讨疾病严重程度的危险因素,以便早期识别和及时治疗。

方法

在这项回顾性研究中,我们收集了 2020 年 1 月 17 日至 2 月 12 日期间浙江省确诊的 COVID-19 患者的数据。根据临床分类的定义,我们将确诊病例分为四种类型,分别总结流行病学和临床特征、实验室和影像学检查结果、治疗方法和转归。此外,我们使用单变量和多变量有序逻辑回归模型探讨 COVID-19 患者疾病严重程度的危险因素。

结果

本研究共纳入 788 例患者,其中 52 例(6.6%)为轻症,658 例(83.5%)为普通型,61 例(7.2%)为重型,17 例(2.2%)为危重型。多变量有序逻辑回归显示,COVID-19 患者疾病严重程度的可能性与男性(比值比[OR] = 1.7,95%置信区间[CI]:1.2-2.6,P = 0.008)、发热(OR = 3.6,95% CI:2.1-6.3,P < 0.001)、咳嗽(OR = 1.7,95% CI:1.0-2.9,P = 0.041)、咯血(OR = 3.4,95% CI:1.1-10.3,P = 0.032)、胃肠道症状(OR = 1.9,95% CI:1.0-3.5,P = 0.047)、高血压(OR = 2.6,95% CI:1.2-5.6,P = 0.013)相关。随着年龄分级的增加,疾病严重程度的风险逐渐升高(≤ 18 岁[OR = 1.0],19-40 岁[OR = 12.7,95% CI:4.5-36.0,P <0.001],41-65 岁[OR = 14.8,95% CI:5.2-42.1,P < 0.001],≥ 66 岁[OR = 56.5,95% CI:17.1-186.5,P < 0.001])。

结论

临床医生应密切关注 COVID-19 患者的这些特征,包括年龄较大、男性、发热、咳嗽、咯血、胃肠道症状和高血压,以便尽早识别疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f491/7346633/dcfcd4c6d8aa/40249_2020_710_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f491/7346633/dcfcd4c6d8aa/40249_2020_710_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f491/7346633/dcfcd4c6d8aa/40249_2020_710_Fig1_HTML.jpg

相似文献

1
Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.中国浙江 COVID-19 患者不同亚型的临床特征及疾病严重程度的危险因素。
Infect Dis Poverty. 2020 Jul 8;9(1):85. doi: 10.1186/s40249-020-00710-6.
2
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎(COVID-19)住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
3
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
4
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病(COVID-19)患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
5
Epidemiological and clinical characteristics of 671 COVID-19 patients in Henan Province, China.中国河南省 671 例 COVID-19 患者的流行病学和临床特征。
Int J Epidemiol. 2020 Aug 1;49(4):1085-1095. doi: 10.1093/ije/dyaa081.
6
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
7
Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study.预测 COVID-19 早期重症患者的标准:一项回顾性观察研究。
J Clin Lab Anal. 2020 Oct;34(10):e23562. doi: 10.1002/jcla.23562. Epub 2020 Sep 6.
8
Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.应用有序逻辑回归分析确定中国 COVID-19 疾病严重程度的决定因素。
Epidemiol Infect. 2020 Jul 7;148:e146. doi: 10.1017/S0950268820001533.
9
Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: A multicenter retrospective study between January 22nd and February 27th, 2020.2020 年 1 月 22 日至 2 月 27 日期间福建省 199 例新冠肺炎出院患者的临床特征:一项多中心回顾性研究。
PLoS One. 2020 Nov 12;15(11):e0242307. doi: 10.1371/journal.pone.0242307. eCollection 2020.
10
Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.严重 COVID-19 患者住院期间死亡的实验室异常和相关危险因素。
J Clin Lab Anal. 2020 Oct;34(10):e23467. doi: 10.1002/jcla.23467. Epub 2020 Jul 12.

引用本文的文献

1
COVID-19 risk stratification among older adults: a machine learning approach to identify personal and health-related risk factors.老年人中的新冠病毒疾病风险分层:一种用于识别个人及健康相关风险因素的机器学习方法
BMC Public Health. 2025 Jul 29;25(1):2577. doi: 10.1186/s12889-025-23862-2.
2
Unveiling sub-populations in critical care settings: a real-world data approach in COVID-19.揭示重症监护环境中的亚人群:COVID-19中的真实世界数据方法
Front Public Health. 2025 May 15;13:1544904. doi: 10.3389/fpubh.2025.1544904. eCollection 2025.
3
Extrarespiratory, Digestive, and Hepatic Manifestations of COVID-19 in a Moroccan Series.

本文引用的文献

1
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.2020 年 1 月至 3 月在中国浙江省感染 SARS-CoV-2 的患者的病毒载量动态和疾病严重程度:回顾性队列研究。
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
2
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
3
Fecal-Oral Transmission of SARS-COV-2: Practical Implications.
摩洛哥系列研究中新冠病毒病的肺外、消化及肝脏表现
Scientifica (Cairo). 2025 Feb 26;2025:3524776. doi: 10.1155/sci5/3524776. eCollection 2025.
4
Description of Post-discharge Outcomes of Patients with COVID-19 in a Tertiary Referral Center in the Philippines.菲律宾一家三级转诊中心新冠肺炎患者出院后结局描述
Acta Med Philipp. 2024 Jun 14;58(10):82-92. doi: 10.47895/amp.vi0.7072. eCollection 2024.
5
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.新型冠状病毒肺炎的胃肠道症状与疾病严重程度:一项基于日本登记处的回顾性队列研究
J Gastroenterol. 2024 Mar;59(3):195-208. doi: 10.1007/s00535-023-02071-x. Epub 2024 Jan 25.
6
Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis.新型冠状病毒肺炎的胃肠道表现及结局:一项全面的系统评价和荟萃分析
Cureus. 2023 Oct 14;15(10):e47028. doi: 10.7759/cureus.47028. eCollection 2023 Oct.
7
Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic.新冠疫情早期和极晚期因新冠肺炎肺炎住院患者的严重程度及死亡风险因素差异。
Front Med (Lausanne). 2023 Sep 28;10:1238713. doi: 10.3389/fmed.2023.1238713. eCollection 2023.
8
Diagnostic accuracy of clinical signs and symptoms of COVID-19: A systematic review and meta-analysis to investigate the different estimates in a different stage of the pandemic outbreak.COVID-19 临床症状和体征的诊断准确性:一项系统评价和荟萃分析,旨在研究大流行爆发不同阶段的不同估计值。
J Glob Health. 2023 Jul 14;13:06026. doi: 10.7189/jogh.13.06026.
9
Age at SARS-CoV-2 infection and psychological and physical recovery among Chinese health care workers with severe COVID-19 at 28 months after discharge: A cohort study.SARS-CoV-2 感染时的年龄与 COVID-19 出院后 28 个月时患有重症 COVID-19 的中国医护人员的心理和身体康复:一项队列研究。
Front Public Health. 2023 Feb 22;11:1086830. doi: 10.3389/fpubh.2023.1086830. eCollection 2023.
10
Pathologic Characteristics of Digestive Tract and Liver in Patients with Coronavirus Disease 2019.2019冠状病毒病患者消化道和肝脏的病理特征
Gastroenterol Clin North Am. 2023 Mar;52(1):201-214. doi: 10.1016/j.gtc.2022.09.003. Epub 2022 Oct 4.
新型冠状病毒2019(SARS-CoV-2)的粪口传播:实际影响
Gastroenterology. 2020 Oct;159(4):1621-1622. doi: 10.1053/j.gastro.2020.03.066. Epub 2020 Apr 2.
4
COVID-19 and the liver: little cause for concern.新冠病毒与肝脏:无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
5
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
6
2019 Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features.以咯血为首发症状的 2019 新型冠状病毒(COVID-19)肺炎:CT 与临床特征。
Korean J Radiol. 2020 May;21(5):537-540. doi: 10.3348/kjr.2020.0181. Epub 2020 Mar 13.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Sex difference and smoking predisposition in patients with COVID-19.新型冠状病毒肺炎患者的性别差异与吸烟易感性
Lancet Respir Med. 2020 Apr;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X. Epub 2020 Mar 11.
9
COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission.新型冠状病毒肺炎:胃肠道表现及潜在的粪-口传播
Gastroenterology. 2020 May;158(6):1518-1519. doi: 10.1053/j.gastro.2020.02.054. Epub 2020 Mar 3.
10
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.血管紧张素转换酶2(ACE2)作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的受体:分子机制与潜在治疗靶点
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.